Login

Sabrina Kuttruff-Coqui

ORCID: 0009-0009-2998-1598
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5072323941
Research Areas
  • CAR-T cell therapy research
  • Cancer Research and Treatments
  • Biomedical Ethics and Regulation
  • Immunotherapy and Immune Responses
  • Virus-based gene therapy research
  • Nanoplatforms for cancer theranostics
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer Immunotherapy and Biomarkers

Immatics Biotechnologies (Germany)
 2016-2023

 Actively personalized vaccination trial for newly diagnosed glioblastoma
OPENALEX - Publications 
Norbert Hilf Sabrina Kuttruff-Coqui Katrin Frenzel Valesca Bukur Stefan Stevanović and 59 more Cécile Gouttefangeas Michael Platten Ghazaleh Tabatabai Valérie Dutoit Sjoerd H. van der Burg Per thor Straten Francisco Martínez‐Ricarte Berta Ponsati Hideho Okada Ulrik Lassen Arie Admon Christian H. Ottensmeier Alexander Ulges Sebastian Kreiter Andreas von Deimling Marco Skardelly Denis Migliorini Judith R. Kroep Manja Idorn Jordi Rodón Jordi Piró Hans Skovgaard Poulsen Bracha Shraibman Katy J. McCann Regina Mendrzyk Martin Löwer Monika Stieglbauer Cedrik M. Britten David Capper Marij J.P. Welters Juan Sahuquillo Katharina Kiesel Evelyna Derhovanessian Elisa Rusch Lukas Bunse Colette Song Sandra Heesch Claudia Wagner Alexandra Kemmer-Brück Jörg Ludwig John C. Castle Oliver Schoor Arbel D. Tadmor Edward Green Jens Fritsche Miriam Meyer Nina N. Pawlowski Sonja Dorner Franziska Hoffgaard Bernhard Rössler Dominik Maurer Toni Weinschenk Carsten Reinhardt Christoph Huber Hans-Georg Rammensee Harpreet Singh‐Jasuja Uğur Şahin Pierre-Yves Dietrich Wolfgang Wick

10.1038/s41586-018-0810-y article EN Nature 2018-12-19
 Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

Abstract IMA101 is an actively personalized, multi-targeted adoptive cell therapy (ACT), whereby autologous T cells are directed against multiple novel defined peptide-HLA (pHLA) cancer targets. HLA-A*02:01-positive patients with relapsed/refractory solid tumors expressing ≥1 of 8 predefined targets underwent leukapheresis. Endogenous specific for up to 4 were primed and expanded in vitro. Patients received lymphodepletion (fludarabine, cyclophosphamide), followed by T-cell infusion low-dose...

10.1158/2326-6066.cir-22-0444 article EN Cancer Immunology Research 2023-05-12
 Supplemental Figure 10 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

<p>Supplemental Figure 10</p>

10.1158/2326-6066.27026579.v1 preprint NL 2024-09-16
 Supplemental Figure 3 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

<p>Supplemental Figure 3</p>

10.1158/2326-6066.27026573 preprint NL 2024-09-16
 Supplemental Figure 2 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

<p>Supplemental Figure 2</p>

10.1158/2326-6066.27026576 preprint NL 2024-09-16
 Supplemental Figure 4 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

<p>Supplemental Figure 4</p>

10.1158/2326-6066.27026570.v1 preprint NL 2024-09-16
 Supplemental Figure 4 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

<p>Supplemental Figure 4</p>

10.1158/2326-6066.27026570 preprint NL 2024-09-16
 Supplemental Figure 5 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

<p>Supplemental Figure 5</p>

10.1158/2326-6066.27026567.v1 preprint NL 2024-09-16
 Supplemental Figure 3 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

<p>Supplemental Figure 3</p>

10.1158/2326-6066.27026573.v1 preprint NL 2024-09-16
 Supplemental Figure 2 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

<p>Supplemental Figure 2</p>

10.1158/2326-6066.27026576.v1 preprint NL 2024-09-16
 Supplemental Figure 8 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

<p>Supplemental Figure 8</p>

10.1158/2326-6066.27026558 preprint NL 2024-09-16
 Supplemental Figure 1 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

<p>Supplemental Figure 1</p>

10.1158/2326-6066.27026582 preprint NL 2024-09-16
 Supplemental Figure 10 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

<p>Supplemental Figure 10</p>

10.1158/2326-6066.27026579 preprint NL 2024-09-16
 Supplemental Figure 9 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

<p>Supplemental Figure 9</p>

10.1158/2326-6066.27026555 preprint NL 2024-09-16
 Supplemental Figure 5 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

<p>Supplemental Figure 5</p>

10.1158/2326-6066.27026567 preprint NL 2024-09-16
 Supplemental Figure 6 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

<p>Supplemental Figure 6</p>

10.1158/2326-6066.27026564 preprint NL 2024-09-16
 Supplemental Figure 1 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

<p>Supplemental Figure 1</p>

10.1158/2326-6066.27026582.v1 preprint NL 2024-09-16
 Supplemental Figure 8 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

<p>Supplemental Figure 8</p>

10.1158/2326-6066.27026558.v1 preprint NL 2024-09-16
 Supplemental Figure 7 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

<p>Supplemental Figure 7</p>

10.1158/2326-6066.27026561 preprint NL 2024-09-16
 Supplemental Figure 6 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

<p>Supplemental Figure 6</p>

10.1158/2326-6066.27026564.v1 preprint NL 2024-09-16
 Supplemental Figure 9 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

<p>Supplemental Figure 9</p>

10.1158/2326-6066.27026555.v1 preprint NL 2024-09-16
 Supplemental Figure 7 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

<p>Supplemental Figure 7</p>

10.1158/2326-6066.27026561.v1 preprint NL 2024-09-16
 Supplementary Figure 11 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

<p>Supplementary Figure 11</p>

10.1158/2326-6066.27026552 preprint EN 2024-09-16
 Supplementary Figure 11 from Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
OPENALEX - Publications 
Apostolia M. Tsimberidou Kerstin Guenther Börje S. Andersson Regina Mendrzyk Amir Alpert and 36 more Claudia Wagner Anna Nowak Katrin Aslan Arun Satelli Fabian Richter Sabrina Kuttruff-Coqui Oliver Schoor Jens Fritsche Zoe Coughlin Ali S. Mohamed Kerry Sieger Becky Norris Rita Ort Jennifer Beck Henry Hiep Vo Franziska Hoffgaard Manuel Ruh Linus Backert Ignacio I. Wistuba David Fuhrmann Nuhad K. Ibrahim Van K. Morris Bryan K. Kee Daniel M. Halperin Graciela M. Nogueras‐González Partow Kebriaei Elizabeth J. Shpall David Vining Patrick Hwu Harpreet Singh Carsten Reinhardt Cedrik M. Britten Norbert Hilf Toni Weinschenk Dominik Maurer Steffen Walter

<p>Supplementary Figure 11</p>

10.1158/2326-6066.27026552.v1 preprint EN 2024-09-16
Coming Soon ...